HOME >> MEDICINE >> NEWS
Positive study results for methylphenidate transdermal system

Philadelphia, US October 24, 2005 Shire announced at a major medical meeting in Toronto, Canada, that its investigational methylphenidate transdermal system (MTS) demonstrated statistically significant reductions in the symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) and was generally well tolerated in patients aged 6 to 12 in two clinical trials.

"Children with ADHD must cope with symptoms throughout the day and in a variety of environments, such as in the classroom, during after-school activities, or while at home," explained Sharon Wigal, Ph.D., associate clinical professor of Pediatrics at the University of California, Irvine Child Development Center. "While oral methylphenidate has long been a first-line treatment for patients with ADHD symptoms, if approved, this transdermal patch formulation would provide health care professionals and parents the first and only non-oral medication for children with the disorder."

The MTS patch was developed by Noven Pharmaceuticals, Inc. and combines the active ingredient of methylphenidate with Noven's patented DOT Matrix transdermal technology. This transdermal delivery system was designed to provide continuous medication release throughout the day. The transdermal system releases medication that passes through the skin and directly into the blood stream. The patch is water-resistant.

Data from phase II and phase III clinical trials presented Thursday and Friday in Toronto demonstrated statistically significant improvements in the primary and secondary endpoints analyzed for children treated with MTS compared to children treated with placebo.

The phase II analog classroom study included 79 children with ADHD. The patch was worn for nine hours, and efficacy was assessed throughout the day for twelve hours. MTS demonstrated statistically significant improvement over placebo on the measures tested. Behavior, which was measured using the Swanson, Kotkin, Agler, M-Flynn,
'"/>

Contact: Matthew Cabrey
1-484-595-8248
Porter Novelli
24-Oct-2005


Page: 1 2

Related medicine news :

1. Positive results more likely from industry-funded breast cancer trials
2. M. D. Anderson reports first drug activity in T315I-Positive CML, ALL and JAK-2-Positive MPD
3. Positive parenting helps encourage healthy sun habits in children
4. Positive results for ACRUXs lead product in US Phase 3 trial
5. Positive outcome of Medicare drug benefit
6. Positive study results for methylphenidate transdermal system
7. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
8. Penn study finds pro-death proteins required to regulate healthy immune function
9. New study shows promise in reducing surgical risks associated with surgical bleeding
10. New study counts the economic cost of persistent pain in Australia
11. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... ... December 05, 2018 , ... Northeast Delta Human Services ... at North Monroe Baptist Church, 210 Finks Hideaway Rd, Monroe, LA 71203. , ... effort to educate and equip faith leaders to address substance abuse prevention, support ...
(Date:12/5/2018)... ... December 05, 2018 , ... Northcentral University (NCU) has today announced ... starting today and on a weekly rolling basis to registered nurses, the Master ... Executive Leadership (DNP) will prepare degree candidates to become leaders in the high-demand ...
(Date:12/5/2018)... EDMOND, Okla. (PRWEB) , ... December 04, 2018 ... ... will open on January 1st, 2019 at 16 E 4th Street. , The ... medical marijuana license. Earthly Mist staff will work with patients to find the ...
(Date:11/29/2018)... ... November 29, 2018 , ... The National ... Investing in the Future: Why Preventing Chronic Disease is Essential - Prevention Works ... prevention, control, and health promotion. , The paper outlines some of the ...
(Date:11/28/2018)... ... 2018 , ... Shareholders Lori G. Cohen and Sara K. ... speaking at the 23rd Annual American Conference Institute (ACI) Conference on Drug & Medical ... 28 through Nov. 30 at the New York Marriott Marquis. The firm is sponsoring ...
Breaking Medicine News(10 mins):
(Date:11/28/2018)... ... November 28, 2018 , ... ... has been published and is available to view on the company’s global ... X-ray diffraction, published by Rigaku Oxford Diffraction , serving the X-ray analysis ...
(Date:11/28/2018)... ... ... Physician Partners of America welcomes Neil Ellis , M.D., M.T.C.M, to its ... Leal , as an interventional pain management specialist in the clinic, which is the ... double board-certified in Anesthesiology and Interventional Pain Medicine by the American Board of Anesthesiology. ...
(Date:11/28/2018)... , ... November 28, 2018 , ... ... of the Simulation Alliance of Pennsylvania, Ohio, and West Virginia (SimPOW) at their ... session. SimPOW founders Suzan Kardong-Edgren and Dana Bargerstock were recognized in the opening ...
Breaking Medicine Technology:
Cached News: